These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23927048)

  • 1. α-Synuclein as an intrinsically disordered monomer--fact or artefact?
    Coelho-Cerqueira E; Carmo-Gonçalves P; Pinheiro AS; Cortines J; Follmer C
    FEBS J; 2013 Oct; 280(19):4915-27. PubMed ID: 23927048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial in-cell NMR of human α-synuclein: a disordered monomer by nature?
    Binolfi A; Theillet FX; Selenko P
    Biochem Soc Trans; 2012 Oct; 40(5):950-4. PubMed ID: 22988846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. α-Synuclein in central nervous system and from erythrocytes, mammalian cells, and Escherichia coli exists predominantly as disordered monomer.
    Fauvet B; Mbefo MK; Fares MB; Desobry C; Michael S; Ardah MT; Tsika E; Coune P; Prudent M; Lion N; Eliezer D; Moore DJ; Schneider B; Aebischer P; El-Agnaf OM; Masliah E; Lashuel HA
    J Biol Chem; 2012 May; 287(19):15345-64. PubMed ID: 22315227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation.
    Bartels T; Choi JG; Selkoe DJ
    Nature; 2011 Aug; 477(7362):107-10. PubMed ID: 21841800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining the native state of α-synuclein.
    Selkoe D; Dettmer U; Luth E; Kim N; Newman A; Bartels T
    Neurodegener Dis; 2014; 13(2-3):114-7. PubMed ID: 24192542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The remarkable conformational plasticity of alpha-synuclein: blessing or curse?
    Deleersnijder A; Gerard M; Debyser Z; Baekelandt V
    Trends Mol Med; 2013 Jun; 19(6):368-77. PubMed ID: 23648364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pitfalls associated with the use of Thioflavin-T to monitor anti-fibrillogenic activity.
    Coelho-Cerqueira E; Pinheiro AS; Follmer C
    Bioorg Med Chem Lett; 2014 Jul; 24(14):3194-8. PubMed ID: 24835632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamins K interact with N-terminus α-synuclein and modulate the protein fibrillization in vitro. Exploring the interaction between quinones and α-synuclein.
    da Silva FL; Coelho Cerqueira E; de Freitas MS; Gonçalves DL; Costa LT; Follmer C
    Neurochem Int; 2013 Jan; 62(1):103-12. PubMed ID: 23064431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macromolecular crowding in the Escherichia coli periplasm maintains alpha-synuclein disorder.
    McNulty BC; Young GB; Pielak GJ
    J Mol Biol; 2006 Feb; 355(5):893-7. PubMed ID: 16343531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The chaperone activity of α-synuclein: Utilizing deletion mutants to map its interaction with target proteins.
    Rekas A; Ahn KJ; Kim J; Carver JA
    Proteins; 2012 May; 80(5):1316-25. PubMed ID: 22274962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicochemical characterization of the G51D mutation of α-synuclein that is responsible for its severe cytotoxicity.
    Murata T; Tochio N; Utsunomiya-Tate N
    Neurosci Lett; 2021 Aug; 760():136077. PubMed ID: 34161822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dynamic structure of α-synuclein multimers.
    Gurry T; Ullman O; Fisher CK; Perovic I; Pochapsky T; Stultz CM
    J Am Chem Soc; 2013 Mar; 135(10):3865-72. PubMed ID: 23398399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitive fluorescence polarization technique for rapid screening of alpha-synuclein oligomerization/fibrillization inhibitors.
    Luk KC; Hyde EG; Trojanowski JQ; Lee VM
    Biochemistry; 2007 Nov; 46(44):12522-9. PubMed ID: 17927212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A peptide motif consisting of glycine, alanine, and valine is required for the fibrillization and cytotoxicity of human alpha-synuclein.
    Du HN; Tang L; Luo XY; Li HT; Hu J; Zhou JW; Hu HY
    Biochemistry; 2003 Jul; 42(29):8870-8. PubMed ID: 12873148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular insights into the interaction between alpha-synuclein and docosahexaenoic acid.
    De Franceschi G; Frare E; Bubacco L; Mammi S; Fontana A; de Laureto PP
    J Mol Biol; 2009 Nov; 394(1):94-107. PubMed ID: 19747490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of subunit linkages in an engineered homodimeric binding protein to α-synuclein.
    Gauhar A; Shaykhalishahi H; Gremer L; Mirecka EA; Hoyer W
    Protein Eng Des Sel; 2014 Dec; 27(12):473-9. PubMed ID: 25332193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression, purification and characterization of α-synuclein fibrillar specific scFv from inclusion bodies.
    Gupta V; Sudhakaran IP; Islam Z; Vaikath NN; Hmila I; Lukacsovich T; Kolatkar PR; El-Agnaf OMA
    PLoS One; 2020; 15(11):e0241773. PubMed ID: 33156828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interplay of intrinsic disorder and macromolecular crowding on α-synuclein fibril formation.
    Shirai NC; Kikuchi M
    J Chem Phys; 2016 Feb; 144(5):055101. PubMed ID: 26851933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct phases of free α-synuclein--a Monte Carlo study.
    Jónsson SA; Mohanty S; Irbäck A
    Proteins; 2012 Aug; 80(9):2169-77. PubMed ID: 22552968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early sodium dodecyl sulfate induced collapse of α-synuclein correlates with its amyloid formation.
    Basak S; Prasad GV; Varkey J; Chattopadhyay K
    ACS Chem Neurosci; 2015 Feb; 6(2):239-46. PubMed ID: 25369246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.